Discover how proteomic profiling is revolutionizing our understanding of treatment-resistant prostate cancer and paving the way for personalized medicine approaches.
Discover how AKR1C3 and AR-V7 work together to create treatment resistance in advanced prostate cancer and the emerging therapeutic strategies to overcome this challenge.